↓ Skip to main content

Low infliximab serum trough levels and anti-infliximab antibodies are prevalent in rheumatoid arthritis patients treated with infliximab in daily clinical practice: results of an observational cohort…

Overview of attention for article published in BMC Musculoskeletal Disorders, September 2012
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter
1 X user
facebook
1 Facebook page

Citations

dimensions_citation
24 Dimensions

Readers on

mendeley
54 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Low infliximab serum trough levels and anti-infliximab antibodies are prevalent in rheumatoid arthritis patients treated with infliximab in daily clinical practice: results of an observational cohort study
Published in
BMC Musculoskeletal Disorders, September 2012
DOI 10.1186/1471-2474-13-184
Pubmed ID
Authors

Aatke van der Maas, Bart JF van den Bemt, Gertjan Wolbink, Frank HJ van den Hoogen, Piet LCM van Riel, Alfons A den Broeder

Abstract

To get insight in the prevalence of high, or low/no serum infliximab trough levels in patients with low disease activity and if serum trough levels are stable and reliable longitudinally we conducted a prospective cohort study

X Demographics

X Demographics

The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 54 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Germany 1 2%
France 1 2%
United Kingdom 1 2%
Singapore 1 2%
Belgium 1 2%
Unknown 49 91%

Demographic breakdown

Readers by professional status Count As %
Researcher 8 15%
Student > Doctoral Student 6 11%
Other 6 11%
Student > Ph. D. Student 5 9%
Professor > Associate Professor 5 9%
Other 14 26%
Unknown 10 19%
Readers by discipline Count As %
Medicine and Dentistry 24 44%
Agricultural and Biological Sciences 9 17%
Pharmacology, Toxicology and Pharmaceutical Science 2 4%
Chemistry 2 4%
Psychology 2 4%
Other 3 6%
Unknown 12 22%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 29 September 2012.
All research outputs
#17,666,399
of 22,679,690 outputs
Outputs from BMC Musculoskeletal Disorders
#2,879
of 4,025 outputs
Outputs of similar age
#125,150
of 171,470 outputs
Outputs of similar age from BMC Musculoskeletal Disorders
#48
of 72 outputs
Altmetric has tracked 22,679,690 research outputs across all sources so far. This one is in the 19th percentile – i.e., 19% of other outputs scored the same or lower than it.
So far Altmetric has tracked 4,025 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 7.0. This one is in the 22nd percentile – i.e., 22% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 171,470 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 24th percentile – i.e., 24% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 72 others from the same source and published within six weeks on either side of this one. This one is in the 30th percentile – i.e., 30% of its contemporaries scored the same or lower than it.